The content on this site is intended for healthcare professionals only
Dr Paul Cornes presents a talk on optimising supportive care during active cancer treatment amid the COVID-19 pandemic.
He also discusses on the risk of complications from chemotherapy and the optimal dosing and use of filgrastim and pegfilgrastim.
The content and interpretation included are the views and opinions of Dr Cornes and not of Accord Healthcare Ltd. Accord has reviewed the video for code compliance and factual accuracy only and provided funding for the video.
Prescribing information and adverse event reporting information for Accofil (filgrastim) can be viewed here.
Prescribing information and adverse event reporting information for Pelgraz▼ (pegfilgrastim) can be viewed here.
This video is intended for UK Healthcare Professionals only.
ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
KEYNOTE-756 trial shows increased response in ER+/HER2- breast cancer
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC
OncoAlert Round Up for September 15-21, 2023
The Southeast Asian Breast Cancer Symposium; background, aims and successes
OncoAlert Round Up for August 25th - 31st, 2023
OncoAlert Round Up for August 4th - 10th, 2023
Time toxicity: the burden on cancer patients
